Clinical Research Directory
Browse clinical research sites, groups, and studies.
Genes, Proteins, and Metabolites in Drug-resistant Epilepsy (DRE) Patients
Sponsor: Xuanwu Hospital, Beijing
Summary
In patients with drug-resistant epilepsy (DRE), there may be changes at the genetic, proteomic, and metabolomic levels when comparing epileptic tissues from DRE to normal tissues in traumatic brain injury (TBI). These changes could help in understanding the pathophysiological mechanisms of epilepsy and in identifying new therapeutic targets.
Official title: The Changes of Genes, Proteins, and Metabolites in Patients with Drug-resistant Epilepsy
Key Details
Gender
All
Age Range
14 Years - 60 Years
Study Type
OBSERVATIONAL
Enrollment
16
Start Date
2024-11-15
Completion Date
2026-12-31
Last Updated
2024-10-30
Healthy Volunteers
No
Interventions
Routine clinical treatment
Routine clinical treatment is based on the latest international guidelines for DRE.
Locations (1)
Xuanwu Hospital, Capital Medical University
Beijing, China